Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Spotify
SPOT
|
+$189M |
| 2 |
Boeing
BA
|
+$57.2M |
| 3 |
Carvana
CVNA
|
+$23.2M |
| 4 |
ConocoPhillips
COP
|
+$22.6M |
| 5 |
EXE
Expand Energy Corporation Common Stock
EXE
|
+$19.6M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$500M |
| 2 |
Microsoft
MSFT
|
+$426M |
| 3 |
Amazon
AMZN
|
+$245M |
| 4 |
Meta Platforms (Facebook)
META
|
+$194M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$167M |
Sector Composition
| 1 | Technology | 33.9% |
| 2 | Consumer Discretionary | 12.65% |
| 3 | Healthcare | 10.7% |
| 4 | Communication Services | 9.68% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Supernus Pharmaceuticals
SUPN
$2.55B
| $3.92M | ﹤0.01% |
108,400
+800
| +0.7% | +$28.9K |
|
1477
QuantumScape
QS
$5.63B
| $3.92M | ﹤0.01% |
754,700
+16,500
| +2% | +$85.6K |
|
|
NGD
1478
New Gold Inc
NGD
$5.16B
| $3.91M | ﹤0.01% |
1,566,862
+9,500
| +0.6% | +$23.7K |
|
1479
OneSpaWorld
OSW
$2.24B
| $3.89M | ﹤0.01% |
195,700
+1,400
| +0.7% | +$27.9K |
|
1480
Acadia Pharmaceuticals
ACAD
$3.98B
| $3.89M | ﹤0.01% |
212,104
+2,900
| +1% | +$53.2K |
|
1481
ePlus
PLUS
$1.97B
| $3.89M | ﹤0.01% |
52,656
| – | – |
|
1482
OFG Bancorp
OFG
$1.95B
| $3.88M | ﹤0.01% |
91,800
| – | – |
|
1483
Carter's
CRI
$1.08B
| $3.86M | ﹤0.01% |
71,200
| – | – |
|
1484
Ligand Pharmaceuticals
LGND
$3.23B
| $3.86M | ﹤0.01% |
36,000
+900
| +3% | +$96.4K |
|
1485
DigitalBridge
DBRG
$2.2B
| $3.85M | ﹤0.01% |
341,625
+2,700
| +0.8% | +$30.5K |
|
1486
IDEAYA Biosciences
IDYA
$2.16B
| $3.84M | ﹤0.01% |
149,600
+16,500
| +12% | +$424K |
|
1487
Lemonade
LMND
$3.88B
| $3.84M | ﹤0.01% |
104,800
+1,800
| +2% | +$66K |
|
1488
WesBanco
WSBC
$3.03B
| $3.81M | ﹤0.01% |
117,145
+1,100
| +0.9% | +$35.8K |
|
1489
MP Materials
MP
$11.2B
| $3.8M | ﹤0.01% |
243,900
+1,700
| +0.7% | +$26.5K |
|
1490
FB Financial Corp
FBK
$2.86B
| $3.78M | ﹤0.01% |
73,383
-400
| -0.5% | -$20.6K |
|
1491
NCR Voyix
VYX
$1.77B
| $3.76M | ﹤0.01% |
271,659
+2,000
| +0.7% | +$27.7K |
|
1492
Hillman Solutions
HLMN
$1.92B
| $3.74M | ﹤0.01% |
383,900
| – | – |
|
1493
Alamo Group
ALG
$2.49B
| $3.74M | ﹤0.01% |
20,100
+100
| +0.5% | +$18.6K |
|
1494
The Greenbrier Companies
GBX
$1.42B
| $3.73M | ﹤0.01% |
61,200
+400
| +0.7% | +$24.4K |
|
1495
Vishay Intertechnology
VSH
$2.07B
| $3.73M | ﹤0.01% |
220,000
| – | – |
|
1496
Innovative Industrial Properties
IIPR
$1.6B
| $3.71M | ﹤0.01% |
55,700
+300
| +0.5% | +$20K |
|
1497
LGI Homes
LGIH
$1.39B
| $3.71M | ﹤0.01% |
41,481
| – | – |
|
1498
Green Brick Partners
GRBK
$3.21B
| $3.71M | ﹤0.01% |
65,600
-200
| -0.3% | -$11.3K |
|
1499
UFP Technologies
UFPT
$1.54B
| $3.69M | ﹤0.01% |
15,100
+900
| +6% | +$220K |
|
1500
John Wiley & Sons Class A
WLY
$2.19B
| $3.68M | ﹤0.01% |
84,300
| – | – |
|